https://www.avient.com/sites/default/files/2021-01/avient-switzerland-gmbh-published-commercial-register.pdf
P'210614)
1 Rothausstrasse 61
4't 32 Muttenz
Ei Lö Zweck Ei Lö weitere Adressen
1 Die Gesellschaft bezweckt den Erutrerb, die Verwaltung und Veräusserung von
Beteiligungen an Unternehmen, die auf dem Gebiete der Chemie und venruandten
Gebieten tätig sind, insbesondere im Bereich Kunststoffe und Beschichtungen,
namentlich, aber nicht ausschliesslich, Kunststoffpräparationen, Additive und
Pigmente.
https://www.avient.com/sites/default/files/resources/TRA%2520-%25202016%2520Annual%2520Report%2520for%252015%2520Tideman.pdf
lang=En&n=FD9B0E51-1
https://ec.ss.ec.gc.ca/auth/en/Services
about:/
about:/
about:/
General Information
Substance List
CAS RN Substance Name Releases Releases (Speciated VOCs) Disposals Recycling Unit
103231 Bis(2ethylhexyl) adipate 0.0000 N/A N/A N/A tonnes
117817 Bis(2ethylhexyl) phthalate 0.0001 N/A N/A N/A tonnes
85449 Phthalic anhydride N/A N/A N/A N/A tonnes
Extension
73642
Fax:
4164994687
Email:
darryl.chartrand@ch2m.com
Contact Type
Highest Ranking Employee
Name:
Robert Greenop
Position:
Plant Manager
Telephone:
5199385865
Email:
robert.greenop@polyone.com
Mailing Address:
Address Line 1:
City, Province/Territory, Postal Code: None
Country: None
Contact Type
Person who prepared the report
Name:
Najat Kamal
Position:
EHSQ specialist
Telephone:
5148089920
Email:
najat.kamal@polyone.com
Mailing Address:
Delivery Mode: GeneralDelivery
Address Line 1:
City, Province/Territory, Postal Code: None
Country: None
Number of employees:
16
Activities for Which the 20,000Hour Employee
Threshold Does Not Apply:
None of the above
Activities Relevant to Reporting Dioxins,
Furans and Hexacholorobenzene:
None of the above
Activities Relevant to Reporting of Polycyclic
Aromatic Hydrocarbons (PAHs):
Wood preservation using creosote: No
Is this the first time the facility is reporting to
the NPRI (under current or past ownership):
No
Is the facility controlled by another Canadian
company or companies:
No
Did the facility report under other
environmental regulations or permits:
No
Is the facility required to report one or more
NPRI Part 4 substances (Criteria Air
Contaminants):
No
Operating Schedule Days of the Week:
Mon, Tue, Wed, Thu, Fri
Usual Number of Operating Hours per day:
24
Usual Daily Start Time (24h) (hh:mm):
07:00
CAS RN Substance Name Releases Releases (Speciated VOCs) Disposals Recycling Unit
Applicable Programs
CAS RN Substance Name NPRI ON MOE TRA ON MOE Reg 127/01
First report for
this substance to
the ON MOE TRA
103231 Bis(2ethylhexyl) adipate Yes Yes Yes
117817 Bis(2ethylhexyl) phthalate Yes Yes No
85449 Phthalic anhydride Yes Yes No
General Information about the Substance Releases and Transfers of the Substance
CAS RN
Substance
Name
Was the substance
released onsite
The substance will be reported as the sum of releases
to all media (total of 1 tonne or less)
1 tonne or more of a Part 5 Substance
(Speciated VOC) was released to air
103231
Bis(2
ethylhexyl)
adipate
Yes Yes No
117817
Bis(2
ethylhexyl)
phthalate
Yes Yes No
85449
Phthalic
anhydride
No No No
General Information about the Substance Disposals and Offsite Transfers for Recycling
CAS RN
Substance
Name
Was the substance disposed of (onsite or off
site), or transferred for treatment prior to final
disposal
Is the facility required to report on disposals of
tailings and waste rock for the selected reporting
period
Was the substance
transferred offsite for
recycling
103231
Bis(2
ethylhexyl)
adipate
No No No
117817
Bis(2
ethylhexyl)
phthalate
No No No
85449
Phthalic
anhydride
No No No
General Information about the Substance Nature of Activities
CAS RN Substance Name Manufacture the Substance Process the Substance Otherwise Use of the Substance
103231 Bis(2ethylhexyl) adipate For sale/distribution As a formulation component As a byproduct
117817 Bis(2ethylhexyl) phthalate For sale/distribution As a formulation component As a byproduct
85449 Phthalic anhydride As a byproduct As a reactant As a byproduct
TRA Quantifications
CAS RN Substance Name Use, Creation, Contained in Product Quantity Use ranges for public reporting
103231 Bis(2ethylhexyl) adipate Use 0.000 tonnes Yes
103231 Bis(2ethylhexyl) adipate Creation 27.159 tonnes Yes
103231 Bis(2ethylhexyl) adipate Contained in Product 27.159 tonnes Yes
117817 Bis(2ethylhexyl) phthalate Use 0.000 tonnes Yes
117817 Bis(2ethylhexyl) phthalate Creation 0.104 tonnes Yes
117817 Bis(2ethylhexyl) phthalate Contained in Product 0.104 tonnes Yes
85449 Phthalic anhydride Use 4228.7 tonnes Yes
85449 Phthalic anhydride Creation 0.000 tonnes Yes
85449 Phthalic anhydride Contained in Product 4228.7 tonnes Yes
TRA Quantifications Others
CAS RN
Substance
Name
Change in Method
of Quantification
Reasons
for
Change
Description of how the change impact
tracking and quantification of the substance
Description of how an
incident(s) affected
quantifications
Significant
Process
Change
103231
Bis(2
ethylhexyl)
adipate
No
117817
Bis(2
ethylhexyl)
phthalate
No
85449
Phthalic
anhydride
No
CAS RN
Substance
Name
Change in Method
of Quantification
Reasons
for
Change
Description of how the change impact
tracking and quantification of the substance
Description of how an
incident(s) affected
quantifications
Significant
Process
Change
Total Quantity Released (All Media)
CAS RN Substance Name Category Basis of Estimate Detail Code Quantity
103231 Bis(2ethylhexyl) adipate Total Quantity Released O Engineering Estimates 0.0000 tonnes
117817 Bis(2ethylhexyl) phthalate Total Quantity Released O Engineering Estimates 0.0001 tonnes
Onsite Releases Quarterly Breakdown of Annual Releases
CAS RN Substance Name Quarter 1 Quarter 2 Quarter 3 Quarter 4
117817 Bis(2ethylhexyl) phthalate 25 25 25 25
Onsite Releases Reasons for Changes in Quantities Released from Previous Year
CAS RN Substance Name Reasons for Changes in Quantities from Previous Year Comments
103231 Bis(2ethylhexyl) adipate No significant change (i.e.
https://www.avient.com/sites/default/files/resources/Terms_and_Conditions_for_Canada_%2528French_Language%2529.pdf
Le vendeur se réserve le droit d’abandonner tout produit vendu en vertu
des présentes, en tout temps, à moins que l’acheteur et le vendeur ne soient liés par un contrat
cadre préexistant qui empêcherait cet abandon.
4.
L’une ou l’autre des parties peut suspendre l’exécution des présentes (sauf pour
payer le produit déjà reçu) dans les cas suivants: (1) actes de Dieu, incendie, explosion,
inondation, ouragan; (2) grèves, lock-out ou autre perturbation industrielle ou émeute; (3) guerre,
déclarée ou non déclarée; (4) observation des lois, règlements, arrêtés ou règles, pris à l’échelon
fédéral, étatique, municipal ou local, étrangers ou nationaux, notamment les arrêtés ou règlements
de priorité, de rationnement, de répartition ou de préemption, ou l’annulation du permis
d’exploitation d’usine du vendeur ou de l’acheteur; (5) pénurie ou autre défaillance des
installations utilisées pour la fabrication ou le transport, ou pénurie de main-d’œuvre, d’électricité,
de combustibles ou de matières premières; (6) fermeture totale ou partielle du fait du redressement
normal de l’usine du vendeur; ou (7) toute autre cause, de quelque nature ou type que ce soit,
raisonnablement indépendante de la volonté de la partie défaillante, qu’elle soit semblable ou
différente des causes énumérées (une « force majeure »).
https://www.avient.com/sites/default/files/2022-09/Avient Discontinued Operations Financial Information.pdf
Slide 4 - Adjusted Financial Information Recast for Avient Distribution as a Discontinued Operation
Reflects adjusted financial information recast for Avient Distribution as a discontinued operation and includes the use of non-GAAP financial measures, including adjusted gross margin, selling and
administrative expense, operating income, net income, and earnings per share (“EPS”).
G A A P I N C O M E S T A T E M E N T R E C A S T F O R A V I E N T D I S T R I B U T I O N A S A
D I S C O N T I N U E D O P E R A T I O N
Avient Corporation 3
(In millions, except per share data)
Q1 2021 Q2 2021 Q3 2021 Q4 2021 2021 YTD Q1 2022 Q2 2022 YTD 2022
Sales 826.0$ 864.5$ 818.0$ 807.1$ 3,315.6$ 892.2$ 891.0$ 1,783.2$
Cost of sales 562.9 615.9 602.4 590.5 2,371.7 637.8 630.1 1,267.9
Gross margin 263.1 248.6 215.6 216.6 943.9 254.4 260.9 515.3
Selling and administrative 168.7 166.2 162.8 166.4 664.1 152.2 160.8 313.0
Operating income 94.4 82.4 52.8 50.2 279.8 102.2 100.1 202.3
Interest expense, net (19.3) (19.5) (19.0) (17.5) (75.3) (16.9) (16.2) (33.1)
Other income (expense), net 1.6 1.1 1.6 (5.3) (1.0) (0.6) 1.6 1.0
Income before income taxes 76.7 64.0 35.4 27.4 203.5 84.7 85.5 170.2
Income tax (expense) benefit (16.3) (13.8) (2.0) (16.2) (48.3) (20.0) (22.7) (42.7)
Net income from continuing operations 60.4 50.2 33.4 11.2 155.2 64.7 62.8 127.5
Net income from discontinued operations, net of income taxes 19.3 19.2 19.2 17.7 75.4 19.8 21.9 41.7
Net income 79.7 69.4 52.6 28.9 230.6 84.5 84.7 169.2
Net (income) loss attributable to noncontrolling interests (0.4) (0.6) 0.3 0.9 0.2 (0.3) - (0.3)
Net income attributable to Avient common shareholders 79.3$ 68.8$ 52.9$ 29.8$ 230.8$ 84.2$ 84.7$ 168.9$
Earnings per share attributable to Avient common shareholders - Basic
Continuing operations 0.66$ 0.54$ 0.37$ 0.13$ 1.70$ 0.70$ 0.69$ 1.39$
Discontinued operations 0.21$ 0.21$ 0.21$ 0.20$ 0.83$ 0.22$ 0.24$ 0.46$
Total 0.87$ 0.75$ 0.58$ 0.33$ 2.53$ 0.92$ 0.93$ 1.85$
Earnings per share attributable to Avient common shareholders - Diluted
Continuing operations 0.65$ 0.54$ 0.37$ 0.13$ 1.69$ 0.70$ 0.68$ 1.38$
Discontinued operations 0.21$ 0.20$ 0.20$ 0.19$ 0.82$ 0.21$ 0.24$ 0.45$
Total 0.86$ 0.74$ 0.57$ 0.32$ 2.51$ 0.91$ 0.92$ 1.83$
A D J U S T E D F I N A N C I A L I N F O R M A T I O N R E C A S T F O R A V I E N T D I S T R I B U T I O N A S A
D I S C O N T I N U E D O P E R A T I O N
Avient Corporation 4
(In millions, except per share data)
Q1 2021 Q2 2021 Q3 2021 Q4 2021 2021 YTD Q1 2022 Q2 2022 YTD 2022
Sales 826.0$ 864.5$ 818.0$ 807.1$ 3,315.6$ 892.2$ 891.0$ 1,783.2$
Cost of sales 565.1 603.3 585.1 584.6 2,338.1 632.0 632.1 1,264.1
Gross margin 260.9 261.2 232.9 222.5 977.5 260.2 258.9 519.1
Selling and administrative 164.1 164.6 160.1 161.1 649.9 151.3 157.0 308.3
Operating income 96.8 96.6 72.8 61.4 327.6 108.9 101.9 210.8
Interest expense, net (19.3) (19.5) (19.0) (17.5) (75.3) (16.9) (16.2) (33.1)
Other income (expense), net 1.6 1.1 1.5 4.1 8.3 (0.7) 0.7 0.0
Income before income taxes 79.1 78.2 55.3 48.0 260.6 91.3 86.4 177.7
Income tax expense (16.1) (16.3) (10.2) (12.8) (55.4) (20.2) (20.4) (40.6)
Net income from continuing operations 63.0 61.9 45.1 35.2 205.2 71.1 66.0 137.1
Net (income) loss attributable to noncontrolling interests
(0.4) (0.6) 0.3 0.9 0.2 (0.3) - (0.3)
Adjusted Net income attributable to Avient common
shareholders - continuing operations 62.6$ 61.3$ 45.4$ 36.1$ 205.4$ 70.8$ 66.0$ 136.8$
Adjusted earnings per share attributable to Avient
common shareholders - Diluted 0.68$ 0.66$ 0.49$ 0.39$ 2.23$ 0.77$ 0.72$ 1.48$
Weighted average diluted Shares 92.2 92.4 92.2 92.4 92.1 92.3 92.1 92.2
S E G M E N T D A T A R E C A S T F O R A V I E N T D I S T R I B U T I O N A S A D I S C O N T I N U E D
O P E R A T I O N
Avient Corporation 5
(In millions)
Q1 2021 Q2 2021 Q3 2021 Q4 2021 2021 YTD Q1 2022 Q2 2022 2022 YTD
Sales:
Color, Additives and Inks 609.3$ 624.4$ 586.6$ 581.3$ 2,401.6$ 649.5$ 649.1$ 1,298.6$
Specialty Engineered Materials 214.7 238.9 231.7 226.3 911.6 243.1 242.3 485.4
Corporate and Eliminations 2.0 1.2 (0.3) (0.5) 2.4 (0.4) (0.4) (0.8)
Sales 826.0 864.5 818.0 807.1 3,315.6 892.2 891.0 1,783.2
Gross Margin:
Color, Additives and Inks 197.5$ 193.4$ 172.1$ 164.5$ 727.5$ 192.1$ 193.4$ 385.5$
Specialty Engineered Materials 63.1 68.1 61.4 58.3 250.9 68.4 66.0 134.4
Corporate and Eliminations 2.5 (12.9) (17.9) (6.2) (34.5) (6.1) 1.5 (4.6)
Gross Margin 263.1 248.6 215.6 216.6 943.9 254.4 260.9 515.3
Se lling and Administrative Expense :
Color, Additives and Inks 108.7$ 107.1$ 105.3$ 103.3$ 424.4$ 97.6$ 99.8$ 197.4$
Specialty Engineered Materials 30.5 32.3 31.4 31.2 125.4 30.1 30.8 60.9
Corporate and Eliminations 29.5 26.8 26.1 31.9 114.3 24.5 30.2 54.7
Selling and Administrative Expense 168.7 166.2 162.8 166.4 664.1 152.2 160.8 313.0
Operating Income:
Color, Additives and Inks 88.8$ 86.3$ 66.8$ 61.2$ 303.1$ 94.5$ 93.6$ 188.1$
Specialty Engineered Materials 32.6 35.8 30.0 27.1 125.5 38.3 35.2 73.5
Corporate and Eliminations (27.0) (39.7) (44.0) (38.1) (148.8) (30.6) (28.7) (59.3)
Operating Income 94.4 82.4 52.8 50.2 279.8 102.2 100.1 202.3
Earnings Be fore Interest, Taxes,
Depreciation and Amortization (EBITDA):
Color, Additives and Inks 116.2$ 111.6$ 93.4$ 87.6$ 408.8$ 120.5$ 119.5$ 240.0$
Specialty Engineered Materials 40.4 43.9 37.9 35.1 157.3 46.1 42.9 89.0
Corporate and Eliminations (25.3) (39.5) (41.9) (34.6) (141.3) (26.8) (26.0) (52.8)
Other income (expense) 1.6 1.1 1.6 (5.3) (1.0) (0.6) 1.6 1.0
EBITDA 132.9 117.1 91.0 82.8 423.8 139.2 138.0 277.2
N O N - G A A P R E C O N C I L I A T I O N S F O R R E C A S T H I S T O R I C A L R E S U L T S
Avient Corporation 6
(In millions, except per share data)
Avie nt
Special
Items
Adjuste d
Avient Avient
Special
Items
Adjusted
Avient Avient
Special
Items
Adjusted
Avient Avient
Special
Items
Adjusted
Avient Avient
Special
Items
Adjusted
Avie nt
Sales $ 826.0 $ - $ 826.0 $ 864.5 $ - $ 864.5 $ 818.0 $ - $ 818.0 $ 807.1 $ - $ 807.1 $ 3,315.6 $ - $ 3,315.6
Gross margin 263.1 (2.2) 260.9 248.6 12.6 261.2 215.6 17.3 232.9 216.6 5.9 222.5 943.9 33.6 977.5
Selling and administrative expense 168.7 (4.6) 164.1 166.2 (1.6) 164.6 162.8 (2.7) 160.1 166.4 (5.3) 161.1 664.1 (14.2) 649.9
Operating income 94.4 2.4 96.8 82.4 14.2 96.6 52.8 20.0 72.8 50.2 11.2 61.4 279.8 47.8 327.6
Interest expense, net (19.3) - (19.3) (19.5) - (19.5) (19.0) - (19.0) (17.5) - (17.5) (75.3) - (75.3)
Other income (expense), net 1.6 - 1.6 1.1 - 1.1 1.6 (0.1) 1.5 (5.3) 9.4 4.1 (1.0) 9.3 8.3
Income taxes (16.3) 0.2 (16.1) (13.8) (2.5) (16.3) (2.0) (8.2) (10.2) (16.2) 3.4 (12.8) (48.3) (7.1) (55.4)
Net income (loss) attributable to noncontrolling
interests
(0.4) - (0.4) (0.6) - (0.6) 0.3 - 0.3 0.9 - 0.9 0.2 - 0.2
Net income from continuing operations attributable
to Avient shareholders
$ 60.0 $ 2.6 $ 62.6 $ 49.6 $ 11.7 $ 61.3 $ 33.7 $ 11.7 $ 45.4 $ 12.1 $ 24.0 $ 36.1 $ 155.4 $ 50.0 $ 205.4
Net income / EPS $ 0.65 0.03 $ 0.68 $ 0.54 0.13 $ 0.66 $ 0.37 0.13 $ 0.49 $ 0.13 $ 0.26 $ 0.39 $ 1.69 0.54 $ 2.23
Weighted-average diluted shares 92.2 92.2 92.2 92.4 92.4 92.4 92.2 92.2 92.2 92.4 92.4 92.4 92.1 92.1 92.1
Three Months Ended
December 31, 2021
Year Ended
December 31, 2021
Three Months Ended
March 31, 2021
Three Months Ended
June 30, 2021
Three Months Ended
September 30, 2021
N O N - G A A P R E C O N C I L I A T I O N S F O R R E C A S T H I S T O R I C A L R E S U L T S
Avient Corporation 7
(In millions, except per share data)
Avient
Special
Items
Adjusted
Avient Avient
Special
Items
Adjusted
Avient Avient
Special
Items
Adjusted
Avient
Sales $ 892.2 $ - $ 892.2 $ 891.0 $ - $ 891.0 $ 1,783.2 $ - $ 1,783.2
Gross margin 254.4 5.8 260.2 260.9 (2.0) 258.9 515.3 3.8 519.1
Selling and administrative expense 152.2 (0.9) 151.3 160.8 (3.8) 157.0 313.0 (4.7) 308.3
Operating income 102.2 6.7 108.9 100.1 1.8 101.9 202.3 8.5 210.8
Interest expense, net (16.9) - (16.9) (16.2) - (16.2) (33.1) - (33.1)
Other (expense) income, net (0.6) (0.1) (0.7) 1.6 (0.9) 0.7 1.0 (1.0) 0.0
Income taxes (20.0) (0.2) (20.2) (22.7) 2.3 (20.4) (42.7) 2.1 (40.6)
Net income attributable to noncontrolling interests (0.3) - (0.3) - - - (0.3) - (0.3)
Net income from continuing operations attributable
to Avient shareholders
$ 64.4 $ 6.4 $ 70.8 $ 62.8 $ 3.2 $ 66.0 $ 127.2 $ 9.6 $ 136.8
Net income / EPS $ 0.70 0.07 $ 0.77 $ 0.68 0.03 $ 0.72 $ 1.38 0.10 1.48
Weighted-average diluted shares 92.3 92.3 92.3 92.1 92.1 92.1 92.2 92.2 92.2
Three Months Ended
March 31, 2022
Three Months Ended
June 30, 2022
Six Months Ended
June 30, 2022
N O N - G A A P R E C O N C I L I A T I O N S F O R R E C A S T A D J U S T E D E B I T D A
Avient Corporation 8
(In millions)
EBITDA Reconciliation Q1 2021 Q2 2021 Q3 2021 Q4 2021 YTD 2021 Q1 2022 Q2 2022 YTD 2022
Net income from continuing operations – GAAP 60.4$ 50.2$ 33.4$ 11.2$ 155.2$ 64.7$ 62.8$ 127.5$
Income tax expense 16.3 13.8 2.0 16.2 48.3 20.0 22.7 42.7
Interest expense, net 19.3 19.5 19.0 17.5 75.3 16.9 16.2 33.1
Depreciation and amortization from continuing operations 36.9 33.6 36.6 37.9 145.0 37.6 36.3 73.9
EBITDA 132.9 117.1 91.0 82.8 423.8 139.2 138.0 277.2
Special items, before tax 2.4 14.2 19.9 20.6 57.1 6.6 0.9 7.5
Depreciation and amortization included in special items (0.6) 1.4 (0.9) (1.6) (1.7) (2.1) (1.1) (3.2)
Adjusted EBITDA 134.7$ 132.7$ 110.0$ 101.8$ 479.2$ 143.7$ 137.8$ 281.5$
S U M M A R Y O F S P E C I A L I T E M S
Avient Corporation 9
(In millions)
Q1 2021 Q2 2021 Q3 2021 Q4 2021 2021 YTD Q1 2022 Q2 2022 2022 YTD
Cost of sales:
Restructuring costs, including accelerated depreciation (1.8)$ (1.5)$ (5.3)$ (6.0)$ (14.6)$ (4.4)$ (2.6)$ (7.0)$
Environmental remediation costs (0.5) (12.5) (9.4) (0.5) (22.9) (2.0) (3.0) (5.0)
Reimbursement of previously incurred environmental costs 4.5 - - - 4.5 0.6 7.6 8.2
Acquisition related adjustments - 1.4 (2.6) 0.6 (0.6) - - -
Impact on cost of sales 2.2 (12.6) (17.3) (5.9) (33.6) (5.8) 2.0 (3.8)
Selling and administrative expense:
Restructuring, legal and other (1.3) (1.4) - (4.2) (6.9) 2.0 (1.7) 0.3
Acquisition/divestiture related costs (3.3) (0.2) (2.7) (1.1) (7.3) (2.9) (2.1) (5.0)
Impact on selling and administrative expense (4.6) (1.6) (2.7) (5.3) (14.2) (0.9) (3.8) (4.7)
Impact on operating income (2.4) (14.2) (20.0) (11.2) (47.8) (6.7) (1.8) (8.5)
Other income, net - - 0.1 (9.4) (9.3) 0.1 0.9 1.0
Impact on income before income taxes (2.4) (14.2) (19.9) (20.6) (57.1) (6.6) (0.9) (7.5)
Income tax benefit on above special items 0.9 3.4 4.6 4.1 13.0 1.7 0.2 1.9
Tax adjustments (1.1) (0.9) 3.6 (7.5) (5.9) (1.5) (2.5) (4.0)
Impact of special items on net income (2.6)$ (11.7)$ (11.7)$ (24.0)$ (50.0)$ (6.4)$ (3.2)$ (9.6)$
https://www.avient.com/sites/default/files/resources/Novel_Thermoplastic_elastomers_for_overmolding_applications.pdf
The chemistry variations of a few of
these polymers are illustrated in Figure 4.
olycarbonate derived from Bisphenol A (PC) - Totally Amorphous P
oly(acrylonitrile-co-butadiene-styrene) (ABS – 15%-35%AN,5-30%BD,40-60%ST) – Totally amorphous P
C*
Acetal Homopolymer – 98% crystalline
Acetal Copolymer
igure 4.
https://www.avient.com/knowledge-base/article/polymer-services-frequency-asked-questions
4.
https://www.avient.com/sites/default/files/2022-06/Maxxam FR Injection Molding Processing Guide.pdf
Drying non-halogenated materials is suggested.
2 hours @ 100 (38)
Moisture Range
(%)
Not required
https://www.avient.com/sites/default/files/2023-10/LubriOne Product Selection Guide.pdf
Steel – Static 0.25 0.46 0.18 0.15 0.12 0.19 0.11 0.14 0.13 0.24 0.17 0.17
Impact
Notched Izod Impact (23°C,
3.18 mm, Injection Molded)
J/m ASTM D256A 41 64(6) 110 107 107 70 80 37 37 75 – 69
Thermal Properties
Heat Deflection Temperature ASTM D648
0.45 MPa °C 215(6) – 250 215 216 184 152 151(6) 153(6) 218(6) – –
1.8 MPa °C 65(6) 239(7) 244(6) 210 210 75 94 81.1(6) 88 197(6) – 135(5)
Electrical Properties
Surface Resistivity ohms/sq ASTM D254 – – – 1.30x1012 1.9x1012 5.2x1012 – – – – – 1.0x109
Dielectric Strength (Short Time) kV/mm – – 8.5 – – – – – – – – –
Flammability
Flame Rating Class UL 94 HB – – HB HB HB – HB – – – –
LubriOne™ Internally Lubricated Formulations
NOTES (1) Type I, 5.1mm/min
(2) Type I, 21.3 mm/min
(3) Type I, 50 mm/min
(4) Type I, 5.1mm/min, Break
(5) 3.2 mm thick, Unannealed
(6) 6.35 mm thick, Unannealed
(7) 3.2 mm thick, Annealed
PRODUCT DESCRIPTION UNITS
TEST
METHOD
LB6000-
5024 RS HI
Natural
LB6000-
5021 RS S1
Black
LB6000-
5021 RS X2
Black
LB6000-
5019 X1
Black
LB6700-
5001 RS AF
Black
NN-
000/01M
Black SO
REC
LB6600-
5030 RS
Grey
LB3300-
5010 RS
Natural
LB3300-
5005 RS
Natural
REC
LB3220-
5001 RS C
Natural X1
LB8900-
5010 GP
Grey
LB8900-
5006 RS PE
Natural
LB8900-
5004 RS PE
Natural
LB4200-
5022 Black
LB4200-
5023
Natural
Base Polymer PA 6 PA6/PA66 PA66 PBT PC PKE POM
Lubricant UHMWPE1 UHMWPE UHMWPE UHMWPE UHMWPE MoS22 Graphite UHMWPE UHMWPE UHMWPE Graphite UHMWPE UHMWPE MoS2 UHMWPE
Filler type GF10 GF30 GF30 GF50 GF50 Unfilled GF33 GF20 MI20 GF10 Unfilled GF20 GF30 Unfilled Unfilled
General Properties
Specific Gravity g/cm3 ISO 1183 1.18 1.35 1.39 1.55 1.58 1.14 1.44 1.42 1.46 1.23 1.26 1.34 1.43 1.4 1.35
Mechanical Properties
Tensile Modulus (23°C) MPa ISO 527-1 4250 9500 9000 15500 16600 3500 10600 6300 3330 4000 1630 5300 9250 2470 2150
Tensile Strength (Yield, 23°C) MPa ISO-527-2 97 150 160 205 200 85 164 102 55 60 60 108 99.1 55 50
Tensile Elongation (Break, 23°C) % ISO-527-2 12 2.5 3 2.7 2.4 3.4 2.0 4.2 8 2.5 46 3.7 1.5 11 11
Flexural Strength (23°C) MPa ISO 178 103 – – 285 265 108 215 127 78 85 38 155 117 73 68
Flexural Modulus (23°C) MPa ISO 178 3250 – – 12400 11100 2690 9000 4700 3000 3100 1380 4600 5450 2210 2070
Impact
Charpy Notched Impact Strength
(23°C, Injection Molded)
kJ/m^2 ISO 179 14 12 10 15 10 3 6 7.7 4.3 12 15 10 7.6 8 5
Charpy Unnotched Impact
Strength (23°C, Injection Molded)
kJ/m^2 ISO 179 82 55 61 75 60 65 50 47 69 - NB 63 36 NB NB
Thermal Properties
Deflection Temperature Under Load
1.8 Mpa, Unannealed
°C ISO 75-2/A 107 – – 204 – 73 235 – – – 90 210 204 86 80
Cofficient of Friction (CoF) & Wear Rate
CoF vs.
https://www.avient.com/sites/default/files/2022-06/MEVOPUR Bio-based Solutions Application Bulletin_CN %281%29.pdf
在不限制本声明的一般性的情况下,不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用:
(1) 接触人体组织或体液长达30天或更长时间;
(2)“整形”(整容或重建)手术;
(3) 生殖植入物或任何节育器械;或者
(4) 用于支持或维持人类生命的永久性(超过30天)植入式医疗器械中的任何关键组件。
https://www.avient.com/sites/default/files/2022-08/MEVOPUR Special Effect Colors Application Bulletin_CN.pdf
在不限制本声明的一般性的情况下,不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用:
(1) 接触人体组织或体液长达30天或更长时间;
(2)“整形”(整容或重建)手术;
(3) 生殖植入物或任何节育器械;或者
(4) 用于支持或维持人类生命的永久性(超过30天)植入式医疗器械中的任何关键组件。